Clinical & Health Data Management - software & AI news

Daily news on software, AI, and companies shaping clinical & health data management.

Showing 309 results
A wearable biosensor on a patient's skin in a clinical setting.

Jul 22, 2026

Trinity Biotech's Wearable Sensors May Guide Drug Delivery

Trinity Biotech has entered a strategic partnership with Latch Medical to enhance drug delivery through innovative biosensor technology.The collaboration aims to integrate Trinity Biotech's CGM+ wearable biosensor platform with Latch Medical's intradermal drug delivery system, Pharma Latch™. This partnership seeks to leverage real-time metabolic data for more personalized therapeutic interventions in managing diabetes, obesity, and other metabolic disorders. By combining advanced biosensing with
A syringe above skin in a clinical setting

Jul 22, 2026

Trinity Biotech (NASDAQ: TRIB) plans equity-backed Latch Medical tie-up in CGM-guided drug delivery

Trinity Biotech has announced a strategic partnership with Latch Medical to advance drug delivery solutions guided by continuous glucose monitoring (CGM) technology. This collaboration aims to integrate Trinity Biotech's CGM+ biosensor platform with Latch Medical's innovative intradermal drug delivery system, potentially enhancing treatment options for metabolic conditions such as diabetes and obesity.The partnership will leverage real-time metabolic data from the CGM+ platform to optimize thera
A minimalist representation of an EEG electrode and brain waves.

Jul 21, 2026

Natus expands access to autoSCORE AI analysis through BRAIN QUICK Software

Natus Medical has enhanced its BRAIN QUICK Software by integrating the autoSCORE AI analysis tool, significantly improving access to automated EEG interpretation across Europe and beyond.This update follows the successful launch of autoSCORE with Natus NeuroWorks EEG Software in the U.S. in August 2024, and its subsequent CE mark approval for international markets in March. The incorporation of this AI tool is part of Natus's ongoing commitment to advancing neurodiagnostic technologies, aiming t
A minimalist illustration of a heart and echocardiogram waveform on a solid background.

Jul 20, 2026

Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients

Ventripoint Diagnostics has announced that its VMS+ technology will play a crucial role in a pioneering NHS study aimed at detecting chemotherapy-related heart damage in breast cancer patients.The study, named AIRES (Artificial Intelligence Reconstruction of Echocardiography Study), is being conducted at The Royal Wolverhampton NHS Trust and is notable for being the first of its kind to focus specifically on oncology patients undergoing chemotherapy. It will include over 500 participants and aim
A heart silhouette with circuit patterns representing AI in healthcare.

Jul 20, 2026

Bitcot: San Diego Healthcare Software Development Company Driving AI-Powered Digital Health Innovation

Bitcot, a San Diego-based healthcare software development company, is expanding its offerings to enhance AI-driven digital health solutions for U.S. healthcare providers.In response to the increasing demand for AI integration in healthcare, Bitcot is broadening its services to include advanced automation and intelligent applications. This expansion aligns with the pressing need for healthcare organizations to modernize their systems, ensure interoperability, and adopt AI responsibly while safegu
A minimalist illustration of a computer chip and data stream in flat design.

Jul 19, 2026

CMS launches dedicated health technology office as AI and interoperability pressure mounts on hospital IT teams

The Centers for Medicare & Medicaid Services (CMS) has launched a new Office of Health Technology and Products, reflecting a significant shift towards integrating AI and enhancing interoperability within healthcare systems.This new office aims to centralize CMS's technology functions, which will have a direct impact on how health systems manage interoperability and data exchange. The establishment of this office indicates that federal oversight of clinical AI and data sharing is becoming a centr
A flat illustration of an ECG monitor and heart shape on a solid background.

Jul 16, 2026

AI Wearable Diagnostics

AI wearable diagnostics are revolutionizing healthcare by facilitating continuous heart monitoring with compact, AI-driven devices.The mobiCARE Cardiac Monitoring System from SEERS, which has received FDA clearance, integrates wearable ECG technology with AI analysis. This system enables patients to monitor their heart rhythms for extended durations, enhancing remote clinical evaluations. By merging long-term data collection with digital health services, the platform aims to identify arrhythmias
A minimalist illustration of a medical diagnostic tool in a dark color scheme.

Jul 16, 2026

Xenter Raises $58.25 Million Series B To Accelerate TechMed Platform Commercialization

Xenter has successfully secured $58.25 million in Series B funding aimed at advancing its TechMed platform, which integrates diagnostics and AI-driven healthcare intelligence.The funding round, finalized on June 30, included contributions from existing shareholders and healthcare investors who align with Xenter's mission to enhance clinical data connectivity. This capital will facilitate the launch of XenFi, support the development of proprietary medical technologies, and enhance manufacturing c
A breast tissue sample on a tray in a clinical setting, with an AI imaging device in the background.

Jul 16, 2026

How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical Insights

Artificial intelligence (AI) is significantly altering the landscape of preventive healthcare by enhancing early disease detection and providing smarter clinical insights.The integration of AI technologies in healthcare is facilitating faster, data-driven decision-making for clinicians. This transformation is particularly evident in medical imaging, where AI systems are improving the accuracy and speed of disease detection, such as in breast cancer screenings. A notable study in India demonstrat
A minimalist stethoscope and data flow icon representing AI in healthcare

Jul 16, 2026

FPT Launches MediSight Framework to Accelerate AI-Driven Healthcare and Life Sciences Innovation

FPT has unveiled MediSight, an innovative AI framework aimed at transforming healthcare and life sciences through enhanced digital capabilities.The MediSight framework is designed to assist healthcare providers, medical device manufacturers, and pharmaceutical companies in accelerating their digital transformation efforts. It combines autonomous AI digital workers with healthcare-specific applications, enabling organizations to streamline clinical, operational, and regulatory workflows. This int
A clipboard with a data sheet in a clinical workspace

Jul 15, 2026

How fighting data fragmentation spurs innovation in life sciences

The integration of data across life sciences is essential for maximizing the potential of AI and digital health technologies.As life sciences organizations increasingly invest in artificial intelligence and advanced analytics, they face significant challenges due to fragmented data residing in various disconnected systems. This fragmentation can hinder the effectiveness of AI models and digital health applications, as incomplete patient histories or unshared data can lead to suboptimal care and
A smart inhaler on a clinical examination table in a dimly lit room.

Jul 15, 2026

Smart Inhalers Market Size to Reach USD 6.86 Billion by 2035 Driven by AI-Powered Connected Inhalers | SNS Insider

The global market for smart inhalers is projected to experience significant growth, reaching USD 6.86 billion by 2035, driven largely by advancements in AI technology and increasing adoption of connected devices in respiratory care.According to a recent market research report, the smart inhalers market was valued at USD 1.85 billion in 2025, with an anticipated compound annual growth rate (CAGR) of 14.0% from 2026 to 2035. This growth is attributed to a rise in the prevalence of asthma and chron